Gentamicin ototoxicity dissociated from glucose uptake and utilization.

Area of Science:

• Ototoxicity
• Neuroscience
• Pharmacology

Background:

• Aminoglycoside antibiotics, like gentamicin, are known to cause ototoxicity.
• The precise mechanisms underlying gentamicin-induced ototoxicity remain under investigation.
• Glucose metabolism is crucial for cochlear function.

Purpose of the Study:

• To investigate whether gentamicin-induced loss of cochlear microphonic potentials is mediated by interference with glucose transport or metabolism.
• To explore the relationship between gentamicin concentration and its effects on cochlear function and glucose utilization.

Main Methods:

• Guinea pig model with perilymphatic perfusion of gentamicin.
• Measurement of cochlear microphonic potentials.
• Assessment of glucose utilization using radiolabeled deoxyglucose uptake in cochlear tissues.
• Evaluation of glucosamine's effect on cochlear function.

Main Results:

• Gentamicin reduced cochlear microphonics in a dose-dependent manner.
• The presence of glucose did not prevent the final loss of cochlear microphonics.
• Glucosamine did not inhibit cochlear microphonic loss.
• Gentamicin did not affect deoxyglucose uptake in the organ of Corti but reduced it in lateral wall tissues.

Conclusions:

• The findings do not support interference with glucose metabolism as the primary mechanism of gentamicin ototoxicity.
• Gentamicin's ototoxic effects are not directly correlated with impaired glucose utilization in the organ of Corti.
• Further research is needed to elucidate the exact mechanisms of aminoglycoside-induced hearing loss.